What is SYBE stock price today?

SYBE (SYBLEU INC.) stock is trading at $0.06 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is SYBE stock going up or down today?

SYBE stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SYBE stock now?

The decision to buy SYBE depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SYBE a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SYBE based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SYBE stock overvalued or undervalued?

Use our DCF valuation calculator to determine if SYBE is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is SYBE's P/E ratio?

P/E ratio data for SYBE will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is SYBE's market cap?

SYBE (SYBLEU INC.) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is SYBE's price to book ratio?

Price-to-book ratio for SYBE is available on our dashboard along with other valuation metrics.

Does SYBE pay dividends?

SYBE does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is SYBE's dividend yield?

SYBE does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is SYBE stock a good long-term investment?

SYBE's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SYBE's revenue growth rate?

Revenue growth data for SYBE is available on our dashboard with detailed financial statement analysis.

Profitability metrics for SYBE are available on our dashboard with complete income statement analysis.

What are the risks of investing in SYBE?

Key risks for SYBE include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SYBE compare to its competitors?

Compare SYBE to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SYBE's performance and positioning.

What is SYBE's stock price target for 2026?

Our AI model provides price targets for SYBE based on fundamental analysis: Bull case $0.07 (+30%), Base case $0.06 (+15%), Bear case $0.05 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about SYBE?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SYBE. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SYBE's next earnings report?

SYBE reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SYBE - SYBLEU INC.

NYSE * Healthcare * Biotechnology

$0.06

+$0.00 (+0.00%)

About SYBLEU INC.

SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and is based in Bronx, New York. As of April 15, 2024, Sybleu Inc. operates as a subsidiary of Worldwide Holdings, LLC.

SYBE Key Statistics

Market Cap

$0.58M

EPS

$-0.03

How SYBE Compares to Peers

SYBE is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
SYBE(This stock)	$583.74K	N/A	0%	0.0%	-
AMGNAmgen Inc	$187.71B	24.5	0%	0.2%	vs AMGN
GILDGilead Sciences	$173.48B	20.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.35B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.71B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$25.83B	20.0	-0%	0.1%	vs BIIB

SYBLEU INC. Company Information

Headquarters: 1034 Throggs Neck Expressway, Bronx, NY, United States, 10465, undefined
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 17, 2026 at 7:29 AM EDT

Ready to invest in SYBE?

Commission-free trading available. Affiliate links.

Upcoming Events for SYBE

Dashboard

Enter a ticker to analyze